[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
Global Anemia Drugs Market
Pharmaceuticals

Anemia Drugs Market to Reach $21.53 Billion by 2029 | Key Drivers and Future Outlook

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What Is the Growth Rate of the Anemia Drugs Market?#_x000D_

The market size for anemia drugs has been exhibiting robust growth in the past few years. The market is expected to expand substantially, rising from $14.72 billion in 2024 to an increased size of $15.92 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.1%. The notable growth during the historical period can be attributed to numerous factors including an increased prevalence of chronic illnesses, heightened awareness of iron deficiency anemia, a rise in the aging population, improved healthcare availability in developing regions, and a surge in demand for targeted treatments._x000D_

_x000D_

#What Growth Rate Is Forecasted for the Anemia Drugs Market by 2029?#_x000D_

In the upcoming years, a significant expansion is anticipated for the anemia drugs market, with the size reaching up to $21.53 billion in 2029, reflecting a compound annual growth rate (CAGR) of 7.8%. The predicted progress throughout the forecast timeframe can be credited to several factors such as the increased acceptance of personalized medicine, surge in health care investments in emerging markets, the escalation in clinical trials for anemia treatment, a worldwide increase in anemia cases and an enhanced emphasis on producing drugs considering the patient’s needs. The upcoming trends for this period are related to the progress in gene therapy for anemia, modernized delivery systems for iron supplements, creativity in agents that stimulate erythropoiesis, development in diagnostic instruments for detecting anemia, and advancements in anemia treatments taken orally._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=24141&type=smp_x000D_

_x000D_

#Which Key Companies Are Shaping the Future of the Anemia Drugs Market?#_x000D_

Major companies operating in the anemia drugs market are Pfizer Inc., AbbVie Inc., Bayer Aktiengesellschaft, Sanofi S.A., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Fresenius SE & Co. KGaA, Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Biocon Limited, Akebia Therapeutics Inc., Apellis Pharmaceuticals Inc., Rockwell Medical Inc., Pharmacosmos A/S, Shield Therapeutics plc, Covis Pharma GmbH, AdvaCare Pharma LLC, Regen Biopharma Inc., BioLineRx Ltd., Bluebird Bio Inc._x000D_

_x000D_

#Which Factors Are Driving Demand in the Anemia Drugs Industry?#_x000D_

The surge in attention towards personalized medicine is anticipated to stimulate the expansion of the anemia drugs market. This modern medical model customizes healthcare choices and treatments to align with an individual’s genetic profile, lifestyle, and surroundings. The escalating focus on customized medicine is attributed to advancements in genomic sequencing, enabling accurate identification of unique genetic variations associated with diseases and response to treatments. Adapted medicine aids in the manufacturing of anaemia medication by facilitating custom-made therapies based on specific genetic profiles, resulting in improved efficiency of the drug and reduced side effects, leading to enhanced patient outcomes. For example, As per the data gathered by the Personalized Medicine Coalition, a non-profit entity in the U.S, in February 2024, it was revealed that the U.S. Food and Drug Administration (FDA) endorsed 16 innovative individualized therapies for patients suffering from rare diseases in 2023, a substantial increment from 6 in the previous year, 2022. Thus, the amplifying emphasis on personalized medicine contributes to the development of the anemia drugs market._x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=24141&type=smp_x000D_

_x000D_

#How Is the Anemia Drugs Market Segmented by Several Divisions?#_x000D_

The anemia drugs market covered in this report is segmented –_x000D_

_x000D_

1) By Drug Type: Dietary Supplements, Medicines_x000D_

2) By Therapy Type: Oral Iron Therapy, Red Blood Cell Transfusion, Parental Iron Therapy, Other Therapy Types_x000D_

3) By Anemia Type: Iron Deficiency Anemia, Sickle Cell Anemia, Aplastic Anemia, Hemolytic Anemia, Pernicious Anemia, Others Anemia Type_x000D_

4) By Distribution Channel: Hospitals Pharmacy, Online Pharmacy, Pharmacy_x000D_

5) By End-User: Clinic, Healthcare, Home Healthcare_x000D_

_x000D_

Subsegments:_x000D_

1) By Dietary Supplements: Iron Supplements, Vitamin B12 Supplements, Folic Acid Supplements, Multivitamin And Mineral Supplements_x000D_

2) By Medicines: Erythropoiesis-Stimulating Agents (ESAs), Iron Chelating Agents, Corticosteroids, Immunosuppressants, Luspatercept And Related Agents_x000D_

_x000D_

#What are the Emerging Market Trends Driving the Growth of the Anemia Drugs Industry?#_x000D_

Leading corporates in the anemia drugs industry are keen on pioneering drug enhancements such as oral HIF-PHI (hypoxia-inducible factor prolyl hydroxylase inhibitors), aiming to boost iron absorption and increase red blood cell production for a more potent anemia cure. Oral HIF-PHIs are a category of oral drugs that aim at and curtail prolyl hydroxylase enzymes, which have a regulatory function in the hypoxia-inducible factor (HIF) pathway. As an example, GSK plc, a pharmaceutical organization based in the UK, launched Jesduvroq in February 2023. This treatment, tailor-made to boost red blood cell generation and combat anemia in adult patients with chronic kidney disease, consists of an advanced anemia drug system that promotes iron absorption, boosts red blood cell generation, and offers individualized treatments. Jesduvroq proves highly efficient by escalating red blood cell generation and tackling anemia in patients with chronic kidney disease through improved iron absorption, thereby promoting better treatment results._x000D_

_x000D_

#Access The Full Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/anemia-drugs-global-market-report_x000D_

_x000D_

#Which Regions Are Driving Growth in the Anemia Drugs Market?#_x000D_

North America was the largest region in the anemia drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anemia drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Purchase The Full Report Today:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=24141&type=smp_x000D_

_x000D_

#This Report Delivers Insight On: #_x000D_

1. How big is the anemia drugs market, and how is it changing globally?_x000D_

2. Who are the major companies in the anemia drugs market, and how are they performing?_x000D_

3. What are the key opportunities and risks in the anemia drugs market right now?_x000D_

4. Which products or customer segments are growing the most in the anemia drugs market?_x000D_

5. What factors are helping or slowing down the growth of the anemia drugs market?_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong. [KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.